Entering a cell and watching its entire inner machinery at work, how DNA is copied, how proteins are assembled, or how it splits in two, has been, for decades, an impossible dream. Now, scientists at the University of Illinois have recreated everything that happens inside a cell at molecular scale in an unprecedented computational model. Syn3A is the first 4D digital cell, capable of combining time and space to simultaneously represent all the internal processes that drive the life cycle of a minimal prokaryotic organism.
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Atara, Johnson & Johnson, Pierre, Toro, Ultragreen, Xspray.
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Biomarin, Beaubrain, C2N, Circle, Eli Lilly, Enodia, Gyre, Kezar, Trinity, Zuellig.
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Bridgebio, Capricor, Insulet, Intensity, Noah, Otsuka, Personalis, Prelude, Regenxbio, Solid, United.
New hires and promotions in the biopharma and med-tech industries, including: 4basebio, Curanex, Biogene, Edgeone, Fujifilm, Halozyme, Helus, Ipsen, Kenai, Mesoblast, Mindmaze, Poolbeg, Preveceutical, Ratio.
Biopharma deal value reached $61.17 billion in the first two months of 2026, roughly a 60% increase from the $38.11 billion logged in the same period of 2025 and marking the strongest early year total in BioWorld’s records. The surge was driven by unusually strong activity in both months, with $31.16 billion in January and $30.01 billion in February.
RSS
